Stan Kogan
Stan Kogan
@stan-kogan.bsky.social
Epidemiologist • Director of Clinical QI, Chronic Disease & Prevention, NYC H+H • PhD student CUNY SPH • Former NYC DOHMH • #RStats • Tweets are my own
Reposted by Stan Kogan
We wrote an article explaining why you shouldn't put several variables into a regression model and report which are statistically significant - even as exploratory research. bmjmedicine.bmj.com/content/4/1/.... How did we do?
October 27, 2025 at 5:39 PM
Reposted by Stan Kogan
Reposted by Stan Kogan
Another cool study from Tammy Brady and colleagues on BP measurement

Does being in the public (aka not an unattended) and/or noise have an effect on blood pressure?

Apparently not, in the @annalsofim.bsky.social www.acpjournals.org/doi/10.7326/...

Small N caveat

#hypertension #medsky
January 27, 2025 at 11:11 PM
Reposted by Stan Kogan
Our work on immortal time bias "Illustrating the structures of bias from immortal time using directed acyclic graphs" led by Emma Guoyi Yang @yanggy_hku is out at International Journal of Epidemiology: doi.org/10.1093/ije/.... Brief thread:
Illustrating the structures of bias from immortal time using directed acyclic graphs
AbstractBackground. Immortal time is a period of follow-up during which death or the study outcome cannot occur by design. Bias from immortal time has been
doi.org
January 8, 2025 at 8:50 AM
Incredibly proud of all of our @nychealthsystem.bsky.social primary care sites for these accomplishments! We're showing that safety net systems can provide the highest quality primary care for chronic conditions like #hypertension and #diabetes. 🎉
NYC Health + Hospitals Nationally Recognized for Hypertension, Diabetes, and Cholesterol Control - NYC Health + Hospitals
NYC Health + Hospitals today announced that four of its sites were recognized by Million Hearts, a national initiative co-led by the Centers for
www.nychealthandhospitals.org
December 3, 2024 at 8:33 PM
Reposted by Stan Kogan
Text message reminders targeting patients who delay refilling their cardiovascular medications did not improve medication adherence based on pharmacy refill data or reduce clinical events at 12 months.

ja.ma/4irtinM
December 2, 2024 at 4:57 PM
Reposted by Stan Kogan
More than half of all US adults are eligible for semaglutide for diabetes management, weight management, and cardiovascular disease.
#AHA24

Read the JAMA Cardiology study: ja.ma/3YUKDwf
November 18, 2024 at 9:15 PM
Just joined Bluesky and already feeling at home! 😌 #rstats #tidyverse
Bluesky really is the new #rstats twitter because we have the first base R vs tidyverse flame war 🤣
November 17, 2024 at 2:49 AM